These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11195437)

  • 1. [Rh-prophylaxis or not? Recommendations are wanted].
    Belfrage P
    Lakartidningen; 2000 Dec; 97(51-52):6014-5. PubMed ID: 11195437
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for antenatal anti-D prophylaxis.
    Mason G; Glanville T
    Lancet; 2002 Sep; 360(9336):880. PubMed ID: 12243957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unclear about prophylaxis against Rh-immunization. Much is missing from the guidelines of the National Board of Health and Welfare].
    Belfrage P; Nielsen S
    Lakartidningen; 1998 Feb; 95(8):708-10. PubMed ID: 9513309
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of Rh(D) alloimmunization: a cost-benefit analysis.
    Baskett TF; Parsons ML
    CMAJ; 1990 Feb; 142(4):337-9. PubMed ID: 2154307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rh-negative women should receive prenatal prophylaxis].
    Belfrage P; Nielsen S
    Lakartidningen; 2000 Mar; 97(9):1008, 1011. PubMed ID: 10741051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
    Boulet S; Krause C; Tixier H; Bardou M; Sagot P
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should the RhD prophylaxis be adjusted?].
    Georgsen J; Sprogøe U
    Ugeskr Laeger; 2004 Aug; 166(36):3072. PubMed ID: 15446237
    [No Abstract]   [Full Text] [Related]  

  • 9. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pregnancy with Rh-isoimmunization. Results of a retrospective analysis in the maternity hospital "Maichin Dom"].
    Mazneikova V; Dimitrova V; Karag'ozova Zh; Ivanova M; Mikhailova E; Stefanova A; Sl'ncheva B; Tsekova K; Lekova S; Furnadzhieva Ts
    Akush Ginekol (Sofiia); 2001; 40(3):3-7. PubMed ID: 11785364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RCP: prevention in materno-fetal Rh immunization (CNGOF, December 2005). We don't have to forget to control the efficacy of these guidelines, as well as the prescription of the innovating technique in this field].
    Sagot P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):358-9. PubMed ID: 16603404
    [No Abstract]   [Full Text] [Related]  

  • 12. [RhD immunoprophylaxis should be adjusted].
    Bock JE; Larsen JF
    Ugeskr Laeger; 2004 Aug; 166(36):3113. PubMed ID: 15387315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rh-prophylaxis or not? Obstetric departments should make decisions if there are medical reasons which justify the treatment].
    Messeter L
    Lakartidningen; 2000 Dec; 97(51-52):6030-3. PubMed ID: 11195439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
    Benachi A; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
    [No Abstract]   [Full Text] [Related]  

  • 18. RhD negative women. Are we ready to change practice?
    Wray J
    Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
    [No Abstract]   [Full Text] [Related]  

  • 19. [The National Board of Health and Welfare is ready to re-evaluate guidelines on Rh-immunization].
    Swartling PG
    Lakartidningen; 1998 Feb; 95(9):835. PubMed ID: 9531748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rh isoimmunization--why still new cases?].
    Langhoff-Roos J; Tamsen L; Lindberg B
    Lakartidningen; 1985 May; 82(22):2064-5. PubMed ID: 3925265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.